Product information

From Health Canada

Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.

Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.

Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.

New search

Natural Product Number (NPN):
80127470
Market status:
Not Marketed
Licence Status:
Active
Brand name(s):
Benzocaine 7.5mg + Menthol 2.6mg Throat Lozenges ;
Pain Relief Lozenges Regular Strength
Licence holder:
CellChem Pharmaceuticals Inc.
Dosage Form:
Lozenge
Recommended route of administration:

Oral

Recommended dose:
Sub population (Sub Pop.) Quantity (Qty) Frequency (Freq.)
Sub Pop. Age Min. Max. UoM Footnote1 Age Qty Min. Max. UoM Qty Freq. Min. Max. UoM Freq.
Adolescents 9 17 Years 2.0 Lozenge 1 7 daily
Adults 18 Years 2.0 Lozenge 1 9 daily
Children 6 12 Years 2.0 Lozenge 1 5 daily
Recommended use or purpose:
For temporary relief of pain of (minor) sore throat. For the temporary relief of (minor) sore throat. For the temporary relief of coughs. Helps ease/relieve nasal congestion. Makes nasal passages feel clearer.
Risk Information:
Cautions and Warnings 
Keep out of reach of children. In case of overdose, call a poison control centre or get medical help right away. Stop use and ask/consult a doctor/physician/health care practitioner/health care provider/health care professional if cough worsens and persists for more than 7 days, or is accompanied by a fever. Stop use and ask/consult a doctor/physician/health care practitioner/health care provider/health care professional if sore throat is severe, persists for more than two days, or is accompanied by or followed by other symptoms such as fever, headache, rash, swelling, nausea, or vomiting, consult a health care practitioner promptly. Stop use and ask/consult a doctor/physician/health care practitioner/health care provider/health care professional if sore throat symptoms worsen or persist for more than 2 days.
Contra-Indications 
Do not use if allergic to benzocaine.
Known Adverse Reactions 
Allergy alert: Hypersensitivity/allergy is known to occur. In such a case, discontinue use. / Allergy alert: Stop use if hypersensitivity/allergy occurs.
List of medicinal ingredients:
Medicinal ingredients Quantity (Qty) Extract Potency
4-Aminobenzoic acid, ethyl ester 7.5 mg
dl-Menthol 2.6 mg
List of non-medicinal ingredients:
  • Cherry flavour
  • FD&C Red No. 3
  • Isomalt
  • Methylparaben
  • Ponceau 4R
  • Propylparaben
  • Sucralose
Date of licensing:
2023-10-19
Revised date of licence:

Application information

Related information

Compendium of monographs

Contact us

For technical support or if you have general questions concerning the content of this database, please contact the Natural Health Products Directorate (NHPD).

Date modified: